HEALTH OF WOMAN. 2020.5-6(151-152):20-28
Клінічні настанови для акушерів та гінекологів
Американська колегія акушерів та гінекологів (ACOG)
Бюлетень практики ACOG. Номер 223 (Замінює бюлетень з практики номер 148)
Obstet Gynecol. 2020 Jun;135(6):e261-e274. doi: 10.1097/AOG.0000000000003893.

У даній статті представлений оновлений бюлетень ACOG (Американської колегії акушерів та гінекологів) стосовно захворювань щитоподібної залози під час вагітності.
Як тиреотоксикоз, так і гіпотиреоз пов’язані із несприятливими наслідками при вагітності. Також існує стривоженість щодо впливу маніфестного захворювання щитоподібної залози у матері на розвиток плода. На додаток лікарські засоби, які впливають на щитоподібну залозу матері, можуть проникати крізь плаценту та впливати на щитоподібну залозу плода. У цьому документі наведений огляд патофізіологічних змін, пов’язаних із щитоподібною залозою, можливих під час вагітності, та впливу маніфестного чи субклінічного захворювання щитоподібної залози на наслідки для матері та плода.
Ключові слова: вагітність, щитоподібна залоза, тиреотоксикоз, гіпотиреоз, гіпертиреоз, діагностика, алгоритм лікування.

ЛІТЕРАТУРА

1. Vannucchi G, Covelli D, Vigo B, Perrino M, Mondina L, Fugazzola L. 2017. Thyroid volume and serum calcitonin changes during pregnancy. J Endocrinol Invest 40:727-32.

2. Huang SA. 2005. Physiology and pathophysiology of type 3 de-iodinase in humans. Thyroid 15:875-81.

3. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C et al. 2017. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum (published erratum appears in Thyroid 27:1212). Thyroid 27:315-89.

4. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al. 2016. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis (published erratum appears in Thyroid 27:1462). Thyroid 26:1343-421.

5. Bemal J. 2007. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3:249-59.

6. Calvo RM, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contemplé B et al. 2002. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87:1768-77.

7. Korevaar H, Muetzel R, Medici M, Chaker L, Jaddoe VW, de Rijke YB et al. 2016. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol 4:35-43.

8. Thorpe-Beeston J, Nicolaides KH, Snijders RJ, Felton CV, McGregor AM. 1991. Thyroid function in small for gestational age fetuses. Obstet Gynecol 77:701-6.

9. Ecker JL, Musci TJ. 2000. Thyroid function and disease in pregnancy. Curr Probl Obstet Gynecol Fertil 23:109-22.

10. Dong AC, Stagnaro-Green A. 2019. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis. Thyroid 29:278-89. (Systematic Review and Meta-Analysis)

11. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. 1989. Thyrotoxicosis complicating pregnancy. Obstet Gynecol 160:63-70.

12. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. 1994. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946-9.

13. Krassas GE, Poppe K, Glinoer D. 2010. Thyroid function and human reproductive health. Endocr Rev 31:702-55.

14. Pearce EN. 2019. Management of thyrotoxicosis: preconception, pregnancy, and the postpartum period. Endocr Pract 25:62-8.

15. Uenaka M, Tanimura K, Tairaku S, Morioka I, Ebina Y, Yamada H. 2014. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves’ disease. Eur J Obstet Gynecol Reprod Biol 177:89-93.

16. Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN et al. 2014. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Invest 77:94-9.

17. Sheehan PM, Nankervis A, Araujo Junior E, Da SC. 2015. Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab 100:4325-31. (Systematic Review and Meta-Analysis)

18. Matsuura N, Harada S, Ohyama Y, Shibayama K, Fukushi M, Ishikawa N et al. 1997. The mechanisms of transient hypo- thyroxinemia in infants bom to mothers with Graves’ disease. Pediatr Res 42:214-8.

19. McKenzie JM, Zakarija M. 1992. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2:155-9.

20. Weetman AP. 2000. Graves’ disease. N Engl J Med 343:1236-48.

21. van der Kaay DC, Wasserman JD, Palmert MR. 2016. Management of neonates bom to mothers with Graves’ disease. Pediatrics 137:e20151878.

22. Casey BM, Dashe JS, Wells CE, Mclntire DD, Leveno KJ, Cunningham FG. 2006. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 107:337-41.

23. Diéguez M, Herrero A, Avello N, Suarez P, Delgado E, Menéndez E. 2016. Prevalence of thyroid dysfunction in women in early pregnancy: does it increase with maternal age? Clin Endocrinol (Oxf) 84:121-6.

24. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al. 2004. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-38.

25. Tudela CM, Casey BM, Mclntire DD, Cunningham FG. 2012. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol 119:983-8.

26. Wilson KL, Casey BM, Mclntire DD, Halvorson LM, Cunningham FG. 2012. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol 119:315-20.

27. Institute of Medicine. Dietary reference intakes: the essential guide to nutrient requirements. Washington, DC: National Academies Press. 2006. Available at: https:// www.nap.edu/catalog/11537/dietary-reference-intakes-the- essential-guide-to-nutrient-requirements. Retrieved 2020, January 10.

28. Harding KB, Pena-Rosas JP, Webster AC, Yap CM, Payne BA, Ota E et al. Iodine supplementation for women during the preconception, pregnancy and postpartum period. Cochrane Database of Systematic Reviews 2017. Issue 3. Art. No.: CD011761. DOI: 10.1002/14651858.CD011761. pub2. (Systematic Review and Meta-Analysis)

29. Pearce EN, Lazarus JH, Moreno-Reyes R, Zimmermann MB. 2016. Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns. Am J Clin Nutr 104(suppl 3):918S-23S.

30. Casey BM, Leveno KJ. 2006. Thyroid disease in pregnancy. Obstet Gynecol 108:1283-92.

31. Yazbeck CF, Sullivan SD. 2012. Thyroid disorders during pregnancy. Med Clin North Am 96:235-56.

32. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. 2002. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12:63-8.

33. Bryant SN, Nelson DB, Mclntire DD, Casey BM, Cunningham FG. 2015. An analysis of population-based prenatal screening for overt hypothyroidism. Obstet Gynecol 213:565.el-6.

34. Brown RS, Bellisario RL, Botero D, Fournier L, Abrams CA, Cowger ML et al. 1996. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptorblocking antibodies in over one million babies. J Clin Endocrinol Metab 81:1147-51.

35. Casey BM, Dashe JS, Wells CE, Mclntire DD, Byrd W, Leveno KJ et al. 2005. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105:239-45.

36. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF et al. 2008. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112:85-92.

37. Fitzpatrick DL, Russell MA. 2010. Diagnosis and management of thyroid disease in pregnancy. Obstet Gynecol Clin North Am 37:173-93.

38. Haddow JE, Palomaki GE, Allan WC, Wilhams JR, Knight GJ, Gagnon J et al. 1999. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549-55.

39. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ et al. 1999. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 50:149-55.

40. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R et al. 2012. Antenatal thyroid screening and childhood cognitive function (published erratum appears in N Engl J Med 2012;366:1650). N Engl J Med 366:493-501.

41. Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG et al. 2017. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 376:815-25.

42. Hales C, Taylor PN, Channon S, Paradice R, McEwan K, Zhang L et al. 2018. Controlled antenatal thyroid screening H: effect of treating maternal suboptimal thyroid function on child cognition. J Clin Endocrinol Metab 103:1583-91.

43. Korevaar TI, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S et al. 2019. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth. published erratum appears in JAMA 2019;322:1718. JAMA 322:632-41. (Systematic Review and Meta- Analysis)

44. Casey BM, Dashe JS, Spong CY, Mclntire DD, Leveno KJ, Cunningham GF. 2007. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 109:1129-35.

45. Cappola AR, Casey BM. 2019. Thyroid function test abnormalities during pregnancy. JAMA 322:617-9.

46. Fister P, Gaberscek S, Zaletel K, Krhin B, Gersak K, Hojker S. 2009. Thyroid volume changes during pregnancy and after delivery in an iodine-sufficient Republic of Slovenia. Eur J Obstet Gynecol Reprod Biol 145:45-8.

47. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH et al. 2012. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:2543-65.

48. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI et al. 2012. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. American Association of Clinical Endocrinologists and American Thyroid Association Task- force on Hypothyroidism in Adults. published errata appear in Thyroid 2013;23:251. Thyroid 2013;23:129. Thyroid 22:1200-35.

49. Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K et al. 2012. Treatment of Graves’ disease with antithyroid thugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97:2396-403.

50. Brent GA. 2008. Clinical practice. Graves’ disease. N Engl J Med 358:2594-605.

51. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, Pavlove MM, Comelio C, Levalle O et al. 2010. The relationship of preconception thyrotropin levels to requirements for increasing the lévothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid 20:1175-8.

52. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. 2004. Timing and magnitude of increases in lévothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351:241-9.

53. Arafah BM. 2001. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344:1743-9.

54. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. 2011. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 342:d2616. (Systematic Review and Meta-Analysis)

55. Stagnaro-Green A, Pearce E. 2012. Thyroid disorders in pregnancy. Nat Rev Endocrinol 8:650-8.

56. Wang H, Gao H, Chi H, Zeng L, Xiao W, Wang Y et al. 2017. Effect of lévothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA 318:2190-8.

57. Dhillon-Smith R, Middleton U, Sunner KK, Cheed V, Baker K, Farrell-Carver S et al. 2019. Lévothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med 380:1316-25.

58. Yeo CP, Khoo DH, Eng PH, Tan HK, Yo SL, Jacob E. 2001. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol (Oxf) 55:391-8.

59. Kinomoto-Kondo S, Umehara N, Sato S, Ogawa K, Fuji- wara T, Arata N et al. 2017. The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case-control study. Arch Gynecol Obstet 295:87-93.

60. Niemeijer MN, Grooten D, Vos N, Bais JM, van der Post JA, Mol BW et al. 2014. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Obstet Gynecol 211:150.el-15. (Systematic Review and Meta-Analysis)

61. Sheffield JS, Cunningham FG. 2004. Thyrotoxicosis and heart failure that complicate pregnancy. Obstet Gynecol 190:211-7.

62. Siu C, Zhang X, Yung C, Kung AW, Lau C, Tse H. 2007. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab 92:1736-1742.

63. Vydt T, Verhelst J, De Keulenaer G. 2006. Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy? Acta Cardiol 61:115-7.

64. Brand F, Liégeois P, Langer B. 2005. One case of fetal and neonatal variable thyroid dysfunction in the context of Graves’ disease. Fetal Diagn Ther 20:12-5.

65. Cohen O, Pinhas-Hamiel O, Sivan E, Dolitski M, Lipitz S, Achiron R. 2003. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenat Diagn 23:740-2.

66. Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M et al. 2005. Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90:6093-8.

67. Hegedüs L. 2004. Clinical practice. The thyroid nodule. N Engl J Med 351:1764-71.

68. Kwong N, Medici M, Angell TE, Liu X, Marqusee E, Cibas ES et al. 2015. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab 100:4434-40.

69. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L et al. 2016. American Association of Clinical Endocrinologists, American College of Endocrinology, and Assoda- zione Mediri Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules —2016 update. Endocr Pract 22:622-39.

70. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A et al. 2001. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Thyroid Cancer Study Group. Lancet 357:1644-50.

71. Nathan N, Sullivan SD. 2014. Thyroid disorders during pregnancy. Endocrinol Metab Clin North Am 43:573-97.

72. Stagnaro-Green A, Glinoer D. 2004. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 18:167-81.

73. Muller AF, Drexhage HA, Berghout A. 2001. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22:605-30.

74. Bergink V, Pop VJ, Nielsen PR, Agerbo E, Munk-Olsen T, Liu X. 2018. Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study. Psychol Med 48:1291-8.

75. Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM et al, editors. 2018. Wilhams obstetrics. 25th ed. New York, NY: McGraw-Hill Education.

76. Lucas A, Pizarro E, Granada ML, Salinas I, Roca J, San- martl A. 2005. Postpartum thyroiditis: long-term follow-up. Thyroid 15:1177-81.

77. Premawardhana LD, Parkes AB, Amman F, John R, Darke C, Adams H et al. 2000. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 85:71-5.